Haematologic Technologies produces coagulation proteins, antibodies, and factor deficient plasmas for research.
Industry
Sector :
Subsector :
founded date
01.01.1987
Company Type
For Profit
IPO status
Private
Description
With over 30 years of experience in protein chemistry, Prolytix (formerly Haematologic Technologies) offers research and development services, characterization by high-resolution mass spectrometry, GxP testing, and custom collection devices to clients worldwide. They use an agile, consultative approach to support product development from discovery through GMP release, providing proven CMC and regulatory expertise. Prolytix is the go-to partner for protein therapeutic projects, offering accessible, attentive, and seasoned teams for routine to complex projects. To learn more, visit GoProlytix.com.